Figure 4.

Kaplan Meier postrejection pancreas graft survival in patients who developed ACR, AMR-E, or AMR-L, compared with posttransplantation pancreas graft survival in nonrejectors (NONE). The overall comparison was significantly different (log rank P = 0.001, Wilcoxon P = 0.002). Two-stratum comparisons ACR versus AMR-E, ACR versus AMR-L, AMR-E versus AMR-L, and ACR versus NONE were NS. Patients with AMR-L had significantly lower pancreas survival than nonrejectors (log-rank P < 0.0001, Wilcoxon P = 0.0001).